Výsledky vyhledávání - Weigel, Brenda
- Zobrazuji výsledky 1 - 20 z 66
- Přejít na další stránku
-
1
-
2
-
3
-
4
Associations of Socioeconomic Status, Public vs Private Insurance, and Race/Ethnicity With Metastatic Sarcoma at Diagnosis Autor Diessner, Brandon J., Weigel, Brenda J., Murugan, Paari, Zhang, Lin, Poynter, Jenny N., Spector, Logan G.
Vydáno 2020Text -
5
-
6
Phase 2 trial of Sorafenib in Children and Young Adults with Refractory Solid Tumors: A Report from the Children’s Oncology Group Autor Kim, AeRang, Widemann, Brigitte C., Krailo, Mark, Jayaprakash, Nalini, Fox, Elizabeth, Weigel, Brenda, Blaney, Susan M.
Vydáno 2015Text -
7
Prolonged Subcutaneous Administration of 852A, a Novel Systemic Toll-like Receptor 7 Agonist, to Activate Innate Immune Responses in Patients with Advanced Hematologic Malignancies Autor Weigel, Brenda J., Cooley, Sarah, DeFor, Todd, Weisdorf, Daniel J., Panoskaltsis-Mortari, Angela, Chen, Wei, Blazar, Bruce R., Miller, Jeffrey S.
Vydáno 2012Text -
8
First-dose and steady-state pharmacokinetics of orally administered crizotinib in children with solid tumors: a report on ADVL0912 from the Children’s Oncology Group Phase 1/Pilot... Autor Balis, Frank M., Thompson, Patrick A., Mosse, Yael P., Blaney, Susan M., Minard, Charles G., Weigel, Brenda J., Fox, Elizabeth
Vydáno 2016Text -
9
Historical time-to-progression (TTP) and progression-free survival (PFS) in relapsed/refractory neuroblastoma modern-era (2002-14) patients from Children’s Oncology Group (COG) ear... Autor London, Wendy B, Bagatell, Rochelle, Weigel, Brenda J, Fox, Elizabeth, Guo, Dongjing, Van Ryn, Collin, Naranjo, Arlene, Park, Julie R
Vydáno 2017Text -
10
A Phase 1 Study of Prexasertib (LY2606368), a CHK1/2 Inhibitor, in Pediatric Patients with Recurrent or Refractory Solid Tumors, including CNS Tumors: A Report from the Children’s... Autor Cash, Thomas, Fox, Elizabeth, Liu, Xiaowei, Minard, Charles G., Reid, Joel M., Scheck, Adrienne C., Weigel, Brenda J., Wetmore, Cynthia
Vydáno 2021Text -
11
Expression of FGFR3 and FGFR4 and clinical risk factors associated with progression-free survival in synovial sarcoma(,) Autor Charbonneau, Bridget, Vogel, Rachel Isaksson, Manivel, J. Carlos, Rizzardi, Anthony, Schmechel, Stephen C., Ognjanovic, Simona, Subramanian, Subbaya, Largaespada, David, Weigel, Brenda
Vydáno 2013Text -
12
Patterns of chemotherapy-induced toxicities and outcome in children and adolescents with metastatic rhabdomyosarcoma: A report from the Children’s Oncology Group Autor Gupta, Abha A., Chi, Yueh-Yun, Anderson, James R., Lyden, Elizabeth, Weigel, Brenda, Arndt, Carola, Meyer, William H., Rosenberg, Abby, Hawkins, Douglas S.
Vydáno 2017Text -
13
Identification of aggressive Gardner syndrome phenotype associated with a de novo APC variant, c.4666dup Autor Kiessling, Patrick, Dowling, Eric, Huang, Yajue, Ho, Mai Lan, Balakrishnan, Karthik, Weigel, Brenda J., Highsmith, W. Edward, Niu, Zhiyv, Schimmenti, Lisa A.
Vydáno 2019Text -
14
Phase I Trial of Seneca Valley Virus (NTX-010) in Children with Relapsed / Refractory Solid Tumors: A Report of the Children’s Oncology Group Autor Burke, Michael J., Ahern, Charlotte, Weigel, Brenda J., Poirier, John T., Rudin, Charles M., Chen, Yingbei, Cripe, Timothy, Bernhardt, M. Brooke, Blaney, Susan M.
Vydáno 2014Text -
15
Toxicity and Pharmacokinetics of Actinomycin- D and Vincristine in Children and Adolescents: Children’s Oncology Group Study ADVL06B1. Autor Skolnik, Jeffrey, Hall, David, Barkauskas, Donald A., Moorthy, Ganesh, Larson, Thomas R., Fox, Elizabeth, Weigel, Brenda J., Berg, Stacey L., Reid, Joel M.
Vydáno 2021Text -
16
A Phase I Study of Entinostat in Children and Adolescents with Recurrent or Refractory Solid Tumors, Including CNS Tumors: Trial ADVL1513, Pediatric Early Phase-Clinical Trial Netw... Autor Bukowinski, Andrew, Chang, Bill, Reid, Joel M., Liu, Xiaowei, Minard, Charles G., Trepel, Jane B., Lee, Min-Jung, Fox, Elizabeth, Weigel, Brenda J.
Vydáno 2021Text -
17
Insights into the mechanism of FTY720 and compatibility with regulatory T cells for the inhibition of graft-versus-host disease (GVHD) Autor Taylor, Patricia A., Ehrhardt, Michael J., Lees, Christopher J., Tolar, Jakub, Weigel, Brenda J., Panoskaltsis-Mortari, Angela, Serody, Jonathan S., Brinkmann, Volker, Blazar, Bruce R.
Vydáno 2007Text -
18
A Therapeutic Trial of Decitabine and Vorinostat in Combination with Chemotherapy for Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) Autor Burke, Michael J., Lamba, Jatinder K, Pounds, Stanley, Cao, Xueyuan, Ghodke-Puranaik, Yogita, Lindgren, Bruce R., Weigel, Brenda J., Verneris, Michael R., Miller, Jeffrey S.
Vydáno 2014Text -
19
Phase II Study of Cixutumumab in Combination with Temsirolimus in Pediatric Patients and Young Adults with Recurrent or Refractory Sarcoma: A Report from the Children’s Oncology Gr... Autor Wagner, Lars M., Fouladi, Maryam, Ahmed, Atif, Krailo, Mark D., Weigel, Brenda, DuBois, Steven G., Doyle, L. Austin, Chen, Helen, Blaney, Susan M.
Vydáno 2014Text -
20
Intensive Multiagent Therapy, Including Dose-Compressed Cycles of Ifosfamide/Etoposide and Vincristine/Doxorubicin/Cyclophosphamide, Irinotecan, and Radiation, in Patients With Hig... Autor Weigel, Brenda J., Lyden, Elizabeth, Anderson, James R., Meyer, William H., Parham, David M., Rodeberg, David A., Michalski, Jeff M., Hawkins, Douglas S., Arndt, Carola A.S.
Vydáno 2016Text